Emergence of t(3;21)(q26.2;q22) during eltrombopag treatment in a patient with relapsed aplastic anemia who received chemotherapy for angioimmunoblastic T-cell lymphoma

Emergence of t(3;21)(q26.2;q22) during eltrombopag treatment in a patient with relapsed aplastic anemia who received chemotherapy for angioimmunoblastic T-cell lymphoma

A 65-year-old man with nonsevere aplastic anemia received rabbit anti-thymocyte globulin and cyclosporine and partially responded. Six months after the initiation of treatment, he was diagnosed with stage IV angioimmunoblastic T-cell lymphoma and received chemotherapy. PET/CT scan analysis indicated...

Full description

Bibliographic Details
Main Authors:	Fumi Nakamura, Yuka Nakamura, Yasuhito Nannya, Honoka Arai, Kei Shimbo, Yuko Nakamura, Sachiko Seo, Ko Sasaki, Motoshi Ichikawa, Seishi Ogawa, Kinuko Mitani
Format:	Article
Language:	English
Published:	Elsevier 2022-01-01
Series:	Leukemia Research Reports
Subjects:	Eltrombopag Aplastic anemia Myelodysplastic syndromes Angioimmunoblastic t-cell lymphoma 3q26 abnormalities
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213048922000176

Similar Items

The efficacy and the safety of eltrombopag in pediatric patients with severe aplastic anemia: a systematic review
by: Maria Maddalena Marrapodi, et al.
Published: (2023-04-01)

Efficacy and Immunomodulating Properties of Eltrombopag in Aplastic Anemia following Autologous Stem Cell Transplant: Case Report and Review of the Literature
by: Marta Bortolotti, et al.
Published: (2022-03-01)

Safety and efficacy of eltrombopag in patients with aplastic anemia: a systematic review and meta-analysis of randomized controlled trials
by: Huaipeng Guo, et al.
Published: (2024-12-01)

Efficacy of eltrombopag with immunosuppressive therapy for children with acquired aplastic anemia
by: Yufei Zhao, et al.
Published: (2023-01-01)

Correlation of the Plasma Concentration of Eltrombopag With Efficacy in the Treatment of Refractory Aplastic Anemia: A Single-Centre Study in China
by: Wei Zuo, et al.
Published: (2020-11-01)

Response of Eltrombopag in immune thrombocytopenia and acquired idiopathic aplastic anemia: A single-center experience
by: Abdul Muqtadir Abbasi, et al.
Published: (2022-01-01)

Pulmonary embolism in a patient with eltrombopag-treated aplastic anaemia and paroxysmal nocturnal haemoglobinuria clone during COVID-19 pneumonia
by: Bosi Alessandro, et al.
Published: (2022-08-01)

Matched related transplantation versus immunosuppressive therapy plus eltrombopag for first-line treatment of severe aplastic anemia: a multicenter, prospective study
by: Limin Liu, et al.
Published: (2022-08-01)

Predicting Response of Severe Aplastic Anemia to Rabbit-Antithymocyte Immunoglobulin Based Immunosuppressive Therapy Combined With Eltrombopag
by: Ruixin Li, et al.
Published: (2022-05-01)

Budget Impact Of Eltrombopag As First-Line Treatment For Severe Aplastic Anemia In The United States
by: Tremblay G, et al.
Published: (2019-11-01)

Preeclampsia in a pregnant woman with severe aplastic anemia: A case report
by: Ikuno Kawabata, et al.
Published: (2022-12-01)

Comparisons Between Frontline Therapy and a Combination of Eltrombopag Plus Immunosuppression Therapy and Human Leukocyte Antigen-Haploidentical Hematopoietic Stem Cell Transplantation in Patients With Severe Aplastic Anemia: A Systematic Review
by: Yuan Yang, et al.
Published: (2021-04-01)

Exploring the Potential of Eltrombopag: Room for More?
by: Francesco Tarantini, et al.
Published: (2022-05-01)

The state of the art in the treatment of severe aplastic anemia: immunotherapy and hematopoietic cell transplantation in children and adults
by: Agnieszka Piekarska, et al.
Published: (2024-04-01)

Cutaneous involvement in angioimmunoblastic T-cell lymphoma
by: Papadavid Evangelia, et al.
Published: (2010-01-01)

Kawasaki disease as the presenting featare of angioimmunoblastic lymphoma
by: S.Alle Yasin, et al.
Published: (2005-01-01)

Recent Advances in Diagnosis and Therapy of Angioimmunoblastic T Cell Lymphoma
by: Mostafa F. Mohammed Saleh, et al.
Published: (2021-12-01)

Comparison of Splenectomy and Eltrombopag Treatment in the Second-Line Treatment of Immune Thrombocytopenic Purpura
by: Mehmet Can Uğur, et al.
Published: (2021-08-01)

Paroxysmal nocturnal hemoglobinuria‐phenotype cells predict a good response to eltrombopag in patients with refractory aplastic anemia
by: Ken Ishiyama, et al.
Published: (2020-07-01)

Hypercalcemia as a rare presentation of angioimmunoblastic T cell lymphoma: a case report
by: Sana Chams, et al.
Published: (2018-04-01)

Use of bronchoalveolar lavage in diagnosing angioimmunoblastic T‐cell lymphoma: A case report
by: Gaku Yamamoto, et al.
Published: (2022-04-01)

Angioimmunoblastic T-Cell lymphoma: A critical analysis of clinical, morphologic and immunophenotypic features
by: Bal Munita, et al.
Published: (2010-10-01)

Successful treatment of acquired amegakaryocytic thrombocytopenia with eltrombopag and immunosuppressant
by: Hong Tian, et al.
Published: (2022-08-01)

Successful Eltrombopag Therapy in a Child with MYH9-Related Inherited Thrombocytopenia
by: Giuseppe Lassandro, et al.
Published: (2022-11-01)

Considerations in the management of hepatitis C virus-related thrombocytopenia with eltrombopag
by: Danish Fazal, et al.
Published: (2010-01-01)

Real-world experience of treatment with thrombopoietin receptor agonists in anti-thymocyte globulin-naïve patients with aplastic anemia: an observational retrospective analysis in a single institution
by: Masaki Iino, et al.
Published: (2022-12-01)

Angioimmunoblastic T-cell lymphoma presenting with an acute serologic Epstein-Barr virus profile
by: Timothy Beer, et al.
Published: (2015-06-01)

APLASTIC ANEMIA
by: Ni Made Dharma Laksmi, et al.
Published: (2013-07-01)

Familial immune‐mediated aplastic anaemia in six different families
by: Tatsuya Imi, et al.
Published: (2023-08-01)

Immune thrombocytopenia and cerebral thrombophlebitis in a patient on eltrombopag: A rare complication
by: Salma Fares, MD, et al.
Published: (2023-06-01)

In vitro effect of eltrombopag alone and in combination with azacitidine on megakaryopoiesis in patients with myelodysplastic syndrome
by: Francesco D’Alò, et al.
Published: (2021-04-01)

Outcomes of Eltrombopag Treatment and Development of Iron Deficiency in Children with Immune Thrombocytopenia in Turkey
by: Ayça Koca Yozgat, et al.
Published: (2020-08-01)

Angioimmunoblastic T-Cell Lymphoma: A Diagnostic Challenge
by: Jorge Ocampo-Garza, et al.
Published: (2014-12-01)

A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience
by: Demet Çekdemir, et al.
Published: (2019-11-01)

Case Report: Pure Red Cell Aplasia due to Angioimmunoblastic T-Cell Lymphoma
by: Marina Vitorino, et al.
Published: (2020-02-01)

Clinical significance of the increased expression of the WT1 gene in peripheral blood of patients with acquired aplastic anemia
by: Ken Ishiyama, et al.
Published: (2022-11-01)

Elucidation of DNA-Eltrombopag Binding: Electrochemical, Spectroscopic and Molecular Docking Techniques
by: Somaye Cheraghi, et al.
Published: (2023-02-01)

Eltrombopag inhibits the proliferation of Ewing sarcoma cells via iron chelation and impaired DNA replication
by: Torin Waters, et al.
Published: (2020-11-01)

Inactivation of FOXO1 induces T follicular cell polarization and involves angioimmunoblastic T cell lymphoma
by: Meifang Xu, et al.
Published: (2019-12-01)

Angioimmunoblastic T-cell Lymphoma: A Mimic for Lupus
by: Hui Boon Tay, et al.
Published: (2020-07-01)